OHR Pharmaceutical Inc Share Price Nasdaq
Equities
US67778H2004
Biotechnology & Medical Research
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 13.79L 11Cr |
---|---|---|---|---|---|
Net income 2023 * | -1.2Cr -100Cr | Net income 2024 * | - | EV / Sales 2023 * | - |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 86.62% |
1st Jan change | Capi. | |
---|---|---|
+33.37% | 5.08TCr | |
+1.55% | 4.28TCr | |
+49.34% | 4.2TCr | |
-4.22% | 2.95TCr | |
+11.57% | 2.61TCr | |
-21.00% | 1.91TCr | |
+7.36% | 1.31TCr | |
+28.30% | 1.22TCr | |
+23.80% | 1.21TCr |